1. McManus, L.M., Hanahan, D.J., Demopoulos, C.A., and Pinckard, R.N., (1980) Pathobiology of the Intravenous Infusion of Acetyl Glyceryl Ether Phosphorylcholine (AGEPC), a Synthetic Platelet-Activating Factor (PAF), in the Rabbit,J. Immunol., 142, 2919–2924.
2. Sanchez-Crespo, A., Alonso, F., Inarrea, P., Alvarez, V., and Egido, J. (1982) Vascular Actions of Synthetic Paf-Acether (a synthetic platelet-activating factor) in the Rat, Evidence for a Platelet Independent Mechanism,Immunopharmacology 4, 173–185.
3. Braquet, P., and Rola-Pleszczynski, M. (1987) Platelet-Activating Factor and Cellular Immune Responses,Immunol. Today 8, 345–348.
4. Travers, J.B., Li, Q., Kniss, D.A., and Fertel, R.T. (1989) Identification of Functional Platelet-Activating Factor Receptors in Raji Lymphoblasts,J. Immunol. 143, 3708–3713.
5. Nguer, C.M., Pellegrini, O., Galanaud, P., Benveniste, J., Thomas, Y., and Richard, Y. (1992) Regulation of PAF-Acether Receptor Expression in Human B Cell Lines,J. Immunol. 149, 2742–2748.